BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Deng L, Yang X, Fan J, Ding Y, Peng Y, Xu D, Huang B, Hu Z. IL-24-Armed Oncolytic Vaccinia Virus Exerts Potent Antitumor Effects via Multiple Pathways in Colorectal Cancer. Oncol Res 2021;28:579-90. [PMID: 32641200 DOI: 10.3727/096504020X15942028641011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Thangavelu S, Ramanthan S, Velmurugan P, Dhandapani R. Virotherapy. Viral Infections and Antiviral Therapies 2023. [DOI: 10.1016/b978-0-323-91814-5.00030-1] [Reference Citation Analysis]
2 Ling Q, Zheng B, Chen X, Ye S, Cheng Q. The employment of vaccinia virus for colorectal cancer treatment: A review of preclinical and clinical studies. Hum Vaccin Immunother 2022;18:2143698. [PMID: 36369829 DOI: 10.1080/21645515.2022.2143698] [Reference Citation Analysis]
3 Zhu Z, McGray AJR, Jiang W, Lu B, Kalinski P, Guo ZS. Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways. Mol Cancer 2022;21:196. [PMID: 36221123 DOI: 10.1186/s12943-022-01664-z] [Reference Citation Analysis]
4 Jia W, Zhang T, Huang H, Feng H, Wang S, Guo Z, Luo Z, Ji X, Cheng X, Zhao R. Colorectal cancer vaccines: The current scenario and future prospects. Front Immunol 2022;13:942235. [DOI: 10.3389/fimmu.2022.942235] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ren Y, Miao J, Wang Y, Fan Z, Kong X, Yang L, Cheng G. Oncolytic viruses combined with immune checkpoint therapy for colorectal cancer is a promising treatment option. Front Immunol 2022;13:961796. [DOI: 10.3389/fimmu.2022.961796] [Reference Citation Analysis]
6 Luo D, Wang H, Wang Q, Liang W, Liu B, Xue D, Yang Y, Ma B. Senecavirus A as an Oncolytic Virus: Prospects, Challenges and Development Directions. Front Oncol 2022;12:839536. [PMID: 35371972 DOI: 10.3389/fonc.2022.839536] [Reference Citation Analysis]
7 Liu Y, Chen Y, Zhu R, Xu L, Xie HQ, Zhao B. Rutaecarpine Inhibits U87 Glioblastoma Cell Migration by Activating the Aryl Hydrocarbon Receptor Signaling Pathway. Front Mol Neurosci 2021;14:765712. [PMID: 34955744 DOI: 10.3389/fnmol.2021.765712] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]